IQVIA Holdings Inc (NYSE:IQV)
| 220.23 Delayed Data As of Nov 25 |  +2.51 / +1.15%Today’s Change | 165.75 Today|||52-Week Range 285.61 | -21.94% Year-to-Date |
| SECTOR Health Services | INDUSTRY Services to the Health Industry | MARKET CAP $40.9B |
Company Description
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Contact Information
IQVIA Holdings, Inc. 4820 Emperor Boulevard Durham North Carolina 27703 |
Employees
Shareholders
| Individual stakeholders | 5.84% |
| Mutual fund holders | 49.04% |
| Other institutional | 40.68% |
Top Executives
| Ari Bousbib | Chairman, President & Chief Executive Officer |
| James Grant Berkshire | Senior Vice President-Business Operations |
| Ronald Earl Bruehlman | Chief Financial Officer & Executive Vice President |
| Costa Panagos | President-Research & Development Solutions |
| Karl Guenault | Chief Information Officer & Senior Vice President |
